Daymark Wealth Partners LLC Acquires 752 Shares of Zoetis Inc. $ZTS

Daymark Wealth Partners LLC lifted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 8.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 9,543 shares of the company’s stock after purchasing an additional 752 shares during the period. Daymark Wealth Partners LLC’s holdings in Zoetis were worth $1,488,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in ZTS. Brighton Jones LLC boosted its holdings in Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after acquiring an additional 2,978 shares during the last quarter. Alta Advisers Ltd boosted its holdings in Zoetis by 59.1% in the first quarter. Alta Advisers Ltd now owns 2,423 shares of the company’s stock valued at $399,000 after acquiring an additional 900 shares during the last quarter. Mather Group LLC. boosted its holdings in Zoetis by 4.4% in the first quarter. Mather Group LLC. now owns 3,549 shares of the company’s stock valued at $584,000 after acquiring an additional 151 shares during the last quarter. Rossby Financial LCC boosted its holdings in Zoetis by 22.6% in the first quarter. Rossby Financial LCC now owns 4,459 shares of the company’s stock valued at $684,000 after acquiring an additional 822 shares during the last quarter. Finally, Arbor Capital Management Inc. ADV boosted its holdings in Zoetis by 5.7% in the first quarter. Arbor Capital Management Inc. ADV now owns 6,137 shares of the company’s stock valued at $1,002,000 after acquiring an additional 331 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ZTS shares. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Argus reissued a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research note on Tuesday, September 9th. UBS Group cut their target price on Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a research note on Monday, October 20th. Piper Sandler increased their target price on Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Finally, Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and cut their target price for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Zoetis has a consensus rating of “Hold” and a consensus target price of $195.00.

Zoetis Trading Down 1.0%

NYSE:ZTS opened at $143.97 on Thursday. The firm has a market capitalization of $63.80 billion, a price-to-earnings ratio of 24.78, a PEG ratio of 2.34 and a beta of 0.90. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The business’s 50-day moving average price is $147.63 and its two-hundred day moving average price is $153.48. Zoetis Inc. has a 1-year low of $139.34 and a 1-year high of $183.81.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis’s revenue was up 4.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis’s dividend payout ratio (DPR) is currently 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.